First Allied Advisory Services’s AbbVie ABBV Stock Holding History

First Allied Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$9.61M	Sell	109,663 -2,594	-2%	-$244K	0.32%	64
2020 Q2	$11M	Buy	112,257 +26,933	+32%	+$2.37M	0.41%	47
2020 Q1	$6.5M	Sell	85,324 -1,346	-2%	-$115K	0.28%	82
2019 Q4	$7.69M	Buy	86,670 +2,102	+2%	+$175K	0.26%	94
2019 Q3	$6.42M	Buy	84,568 +11	+0%	+$754	0.23%	108
2019 Q2	$6.15M	Buy	84,557 +2,738	+3%	+$215K	0.21%	113
2019 Q1	$6.58M	Buy	81,819 +7,664	+10%	+$627K	0.23%	104
2018 Q4	$6.85M	Buy	74,155 +5,815	+9%	+$511K	0.27%	80
2018 Q3	$6.46M	Buy	68,340 +5,798	+9%	+$550K	0.22%	110
2018 Q2	$5.79M	Sell	62,542 -7,325	-10%	-$715K	0.22%	117
2018 Q1	$6.61M	Sell	69,867 -3,983	-5%	-$438K	0.25%	100
2017 Q4	$7.14M	Sell	73,850 -4,990	-6%	-$470K	0.28%	84
2017 Q3	$7M	Sell	78,840 -2,030	-3%	-$155K	0.3%	74
2017 Q2	$5.86M	Sell	80,870 -782	-1%	-$52.6K	0.26%	96
2017 Q1	$5.33M	Buy	81,652 +4,447	+6%	+$280K	0.28%	88
2016 Q4	$4.83M	Sell	77,205 -1,625	-2%	-$99.2K	0.24%	105
2016 Q3	$4.97M	Sell	78,830 -1,514	-2%	-$98K	0.26%	99
2016 Q2	$4.97M	Sell	80,344 -2,007	-2%	-$122K	0.28%	96
2016 Q1	$4.72M	Buy	82,351 +50	+0.1%	+$2.79K	0.26%	95
2015 Q4	$4.88M	Sell	82,301 -17,390	-17%	-$1M	0.25%	97
2015 Q3	$5.42M	Buy	99,691 +2,362	+2%	+$154K	0.3%	88
2015 Q2	$6.54M	Buy	97,329 +47,571	+96%	+$3.11M	0.29%	89
2015 Q1	$2.92M	Buy	49,758 +1,666	+3%	+$101K	0.19%	133
2014 Q4	$3.15M	Sell	48,092 -3,524	-7%	-$222K	0.23%	102
2014 Q3	$2.99M	Buy	51,616 +19	+0%	+$1.05K	0.24%	92
2014 Q2	$2.92M	Sell	51,597 -144	-0.3%	-$7.55K	0.21%	133
2014 Q1	$2.66M	Sell	51,741 -23,845	-32%	-$1.21M	0.2%	135
2013 Q4	$4M	Sell	75,586 -26,919	-26%	-$1.32M	0.32%	72
2013 Q3	$4.55M	Buy	102,505 +8,111	+9%	+$360K	0.26%	108
2013 Q2	$3.88M	Buy	+94,394	New	+$4.13M	0.31%	85

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

First Allied Advisory Services's ABBV Position: Q3 2020 in Review

First Allied Advisory Services reduced its AbbVie (ABBV) stake by 2.3% in Q3 2020, selling an estimated $244K and leaving 109,663 shares worth $9.61M. The position accounts for 0.32% of the portfolio, ranked #64.

First Allied Advisory Services first reported a position in ABBV in Q2 2013 and has held it in 30 quarters since. The position peaked at $11M in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

First Allied Advisory Services held 109,663 shares of AbbVie worth $9.61M as of Q3 2020.
First Allied Advisory Services sold 2,594 AbbVie shares in Q3 2020, an estimated $244K.
AbbVie made up 0.32% of First Allied Advisory Services's portfolio in Q3 2020, its #64 holding.
First Allied Advisory Services first reported a position in AbbVie in Q2 2013 and has held it in 30 quarters since.
First Allied Advisory Services's AbbVie position peaked at $11M in Q2 2020.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.